| 蔡江义,崔旭,秦岭,等.高危型人乳头瘤病毒基因分型聚合酶链式反应检测技术在宫颈癌筛查中的应用分析[J].安徽医药,2021,25(9):1839-1842. |
| 高危型人乳头瘤病毒基因分型聚合酶链式反应检测技术在宫颈癌筛查中的应用分析 |
| Application analysis of HR-HPV DNA PCR detection technology in cervical cancer screening |
| |
| DOI：10.3969/j.issn.1009-6469.2021.09.033 |
| 中文关键词: 乳头状瘤病毒感染 核酸杂交 宫颈癌 癌前病变筛查 HR-HPV DNA PCR技术 |
| 英文关键词: Papillomavirus infections Nucleic acid hybridization Cervical cancer Precancerous lesions screening HRHPV DNA PCR technology |
| 基金项目: |
|
| 摘要点击次数: 1346 |
| 全文下载次数: 458 |
| 中文摘要: |
| 目的探讨以聚合酶链式反应( PCR)为基础的高危型人乳头瘤病毒( HPV)分型检测在宫颈癌筛查中的应用和诊断价值。方法选取 2016年 6月至 2019年 6月西安航天医院收治的疑似宫颈病变病人 628例，分别采取高危型 HPV分型 PCR技术(HR-HPV DNA PCR)液基薄层细胞学检查( TCT)以及病理组织活检诊断，以病理活检作为诊断宫颈病变的“金标准”，分析高危型 HPV感染与宫颈病，变的关系以及高危型 HPV分型检测技术在宫颈癌筛查中的应用价值。结果 HR-HPV DNA PCR技术的灵敏度为 91.76%，特异度为 91.29%，阳性预测值为 9356%，阴性预测值为 88.93%，符合率为 91.56%，均显著优于 TCT检测方法( P < 0.001)。同时，对 13种 HPV亚型分析发现， 16、18亚型与宫颈癌及癌前病变密切相关( P < 0.05)33、52及 58型次之(P < 0.05)。而且， HPV的感染率随着年龄的增长而增长， >39~49岁病人 HPV感染率为 58.15%、>49~59岁病，人为 64.29%、>59岁病人为 75.41%，均显著高于 20~29岁的年轻病人的 46.40%(P < 0.05)。结论高危型 HPV持续感染是宫颈癌及癌前病变发生的关键因素，以 PCR为基础的高危型 HPV分型检测在宫颈癌筛查中具有较高的应用价值。 |
| 英文摘要: |
| Objective To investigate the application and diagnostic value of high-risk human papillomavirus (HPV) typing based onpolymerase chain reaction (PCR) in the screening of cervical cancer and precancerous lesions.Methods A total of 628 patients withsuspected cervical lesions admitted to Xi'an Aerospace General Hospital from June 2016 to June 2019 were selected. High-risk HPV typing PCR (HR-HPV DNA PCR), thinprep cytology test (TCT) and pathological biopsy were used for diagnosis, and pathological diagnosis was used as the "gold standard" for the diagnosis of cervical lesions. The relationship between high-risk HPV infection and cervical lesions was analyzed.Results The sensitivity of HR-HPV DNA PCR technology was 91.76%, the specificity was 91.29%, the positive predictive value was 9356%, the negative predictive rate was 88.93%, and the coincidence rate was 91.56%, which were significantly better than those of the TCT detection method (P < 0.001). In addition, 13 HPV subtypes were found, 16 and 18 subtypes andcervix cancer and precancerous lesions were closely related (P < 0.05), followed by 33, 52 and 58 subtypes (P < 0.05). Moreover, the HPV infection rate increased with age. The HPV infection rate was 58.15% for patients aged >39-49 years, 64.29% for patients >49-59 years old, and 75.41% for patients >59 years old, which were significantly higher than 46.40% of young patients aged 20-29 (P < 0.05). Conclusions High-risk HPV infection is a key factor in the development of cervical cancer and precancerous lesions. High-risk HPV typing has a high value in the screening of cervical cancer and precancerous lesions. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
